Silver Book Fact

1 and 6-month mortality rates without treatment for sSAS

Waiting for treatment for severe symptomatic aortic stenosis (sSAS) can be deadly, with 1-month mortality at 3.7% and 6-month mortality at 11.6% (measured from the time intervention was recommended).

Malaisrie C, McDonald E, Kruse J, Li Z, et al. Mortality While Waiting for Aortic Valve Replacement. The Annals of Thoracic Surgery. 2014; 98. http://www.annalsthoracicsurgery.org/article/S0003-4975(14)01324-1/pdf

Reference

Title
Mortality While Waiting for Aortic Valve Replacement
Publication
The Annals of Thoracic Surgery
Publication Date
2014
Authors
Malaisrie C, McDonald E, Kruse J, Li Z, et al.
URL
Read Full Resource

Categories

  • Cost of Disease
  • Human Burden

Connected Facts

Related Facts

  • All-cause mortality for aortic valve disorders
    In 2014, all-cause mortality for aortic valve disorders was 34,408 in the U.S.  
  • SAS patient hospitalization costs
    Symptomatic aortic stenosis (SAS) patients who do not undergo treatment cost Medicare as much as $1.3 billion each year due to rehospitalization, prolonged stays, admissions to skilled nursing facilities, and…  
  • Mean 5-Year Cumulative Total Medical Costs Per Medically Managed (No AVR) Severe AS Patient
     
  • Prevalence of AS in Americans 75+
    An estimated 12.4%, or ~2.5 million people ages 75+ in North America, have AS.  
  • Projections of Significant Heart Valve Disease — Diagnosed & Undiagnosed — in the 65+ U.K. Population